| Περίληψη: | Background: Chronic inflammatory demyelinating polyneuropathy (CIDP) as a pure sensory variant is rarely
encountered. Therefore the best treatment option is hard to define.
Case presentations: We reported two middle-aged patients of Caucasian origin, one female and one male, who
over a period of several months presented limbs and gait ataxia. Clinical and neurophysiological examination
revealed only sensory abnormalities. A diagnosis of atypical CIDP was suggested, considering the elevated CSF
protein level and the presence of anti-gangliosides antibodies. Ten and 15 days respectively after initiation of
prednisolone treatment both patients experienced exacerbation of sensory symptoms and emerging of muscle
weakness. Steroids were then substituted by rituximab in the first patient and intravenous immunoglobulin in the
second patient resulting in gradual decrement of symptoms and signs. Two-year follow-up showed no further
deterioration.
Conclusion: Caution should be exercised when treating cases of pure sensory polyneuropathy with high dose
steroids since an unfavorable outcome is possible.
|
|---|
